L. Qi

Prediction of pathological complete response after neoadjuvant therapy in breast cancer using pretreatment core biopsy pathology reports: a pathology-report-driven model with exploratory clinical-laboratory fusion

Pathological complete response (pCR) after neoadjuvant therapy is an important response endpoint in breast cancer. We investigated whether routinely generated pretreatment core biopsy pathology reports could support pCR prediction and whether clinical, preoperative laboratory, and treatment information provided increme...